WO2006063737A1 - Therapie combinatoire impliquant le telmisartan et l'hydrochlorothiazide - Google Patents
Therapie combinatoire impliquant le telmisartan et l'hydrochlorothiazide Download PDFInfo
- Publication number
- WO2006063737A1 WO2006063737A1 PCT/EP2005/013224 EP2005013224W WO2006063737A1 WO 2006063737 A1 WO2006063737 A1 WO 2006063737A1 EP 2005013224 W EP2005013224 W EP 2005013224W WO 2006063737 A1 WO2006063737 A1 WO 2006063737A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- telmisartan
- composition
- hydrochlorothiazide
- angiotensin
- receptor antagonist
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Definitions
- a target blood pressure of ⁇ 140/90 mmHg is recommended and an even lower target of ⁇ 130/80 mmHg for patients with co-morbidities such as diabetes or chronic kidney disease.
- the tablets obtained release the active ingredients rapidly and in a largely pH- independent fashion, with complete release occurring within less than 60 min and release of the major fraction occurring within less than 15 min.
- the dissolution/- disintegration kinetics of the multilayer tablet may be controlled in different ways.
- the layers may dissolve/disintegrate simultaneously.
- the tablet layer comprising HCTZ disintegrates first whereas the layer comprising telmisartan dissolves subsequently.
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Medicinal Preparation (AREA)
Abstract
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BRPI0519656-6A BRPI0519656A2 (pt) | 2004-12-17 | 2005-12-09 | terapia de combinaÇço compreendendo telmisartan e hidroclorotiazida |
AU2005315855A AU2005315855A1 (en) | 2004-12-17 | 2005-12-09 | Combination therapy comprising telmisartan and hydrochlorothiazide |
EA200701159A EA200701159A1 (ru) | 2004-12-17 | 2005-12-09 | Комбинированное лекарственное средство, включающее телмисартан и гидрохлортиазид |
JP2007545905A JP2008524136A (ja) | 2004-12-17 | 2005-12-09 | テルミサルタンとヒドロクロロチアジドを含む併用療法 |
EP05814002A EP1827424A1 (fr) | 2004-12-17 | 2005-12-09 | Therapie combinatoire impliquant le telmisartan et l'hydrochlorothiazide |
CA002589493A CA2589493A1 (fr) | 2004-12-17 | 2005-12-09 | Therapie combinatoire impliquant le telmisartan et l'hydrochlorothiazide |
NO20072325A NO20072325L (no) | 2004-12-17 | 2007-05-04 | Kombinasjonsterapi omfattende telmisartan og hydroklortiazid |
IL183944A IL183944A0 (en) | 2004-12-17 | 2007-06-14 | Combination therapy comprising telmisartan and hydrochlorothiazide |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US63706204P | 2004-12-17 | 2004-12-17 | |
US60/637,062 | 2004-12-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2006063737A1 true WO2006063737A1 (fr) | 2006-06-22 |
Family
ID=35589356
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2005/013224 WO2006063737A1 (fr) | 2004-12-17 | 2005-12-09 | Therapie combinatoire impliquant le telmisartan et l'hydrochlorothiazide |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP1827424A1 (fr) |
JP (1) | JP2008524136A (fr) |
KR (1) | KR20070097511A (fr) |
CN (1) | CN101080225A (fr) |
AR (1) | AR052052A1 (fr) |
AU (1) | AU2005315855A1 (fr) |
BR (1) | BRPI0519656A2 (fr) |
CA (1) | CA2589493A1 (fr) |
EA (1) | EA200701159A1 (fr) |
IL (1) | IL183944A0 (fr) |
NO (1) | NO20072325L (fr) |
PE (1) | PE20060768A1 (fr) |
TW (1) | TW200637546A (fr) |
UY (1) | UY29274A1 (fr) |
WO (1) | WO2006063737A1 (fr) |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007060170A2 (fr) * | 2005-11-24 | 2007-05-31 | Boehringer Ingelheim International Gmbh | Comprimé bicouche comprenant du telmisartan et un diurétique |
WO2010013835A2 (fr) * | 2008-07-31 | 2010-02-04 | Takeda Pharmaceutical Company Limited | Composition pharmaceutique solide |
US20100143465A1 (en) * | 2007-03-14 | 2010-06-10 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition |
WO2010063995A2 (fr) * | 2008-12-04 | 2010-06-10 | Arrow International Limited | Telmisartan en formulations diurétiques |
EP2203158A2 (fr) | 2007-10-30 | 2010-07-07 | Dr. Reddy's Laboratories, Ltd. | Formulations pharmaceutiques comprenant du telmisartan et de l'hydrochlorotiazide |
US20100233265A1 (en) * | 2007-10-19 | 2010-09-16 | Kai Suzuki | Matrix-type pharmaceutical solid preparation |
US7812046B2 (en) | 2002-08-10 | 2010-10-12 | Bethesda Pharmaceuticals, Inc. | PPAR ligands that do not cause fluid retention, edema or congestive heart failure |
EP2252273A1 (fr) | 2008-03-19 | 2010-11-24 | Ratiopharm GmbH | Composition pharmaceutique solide incluant un antagoniste non peptidique du récepteur de l angiotensine ii et un diurétique |
WO2010146187A2 (fr) | 2009-06-19 | 2010-12-23 | Krka, Tovarna Zdravil, D.D., Novo Mesto | Procédé pour la préparation de telmisartan |
WO2011002425A3 (fr) * | 2009-07-02 | 2011-03-03 | Bilgig Mahmut | Composition pharmaceutique présentant une solubilité et une stabilité accrues |
WO2011025467A1 (fr) | 2009-08-24 | 2011-03-03 | Bilgic Mahmut | Formes posologiques solides comprenant du telmisartan |
WO2011002423A3 (fr) * | 2009-07-02 | 2011-03-03 | Mahmut Bilgic | Composition pharmaceutique augmentant la solubilité |
WO2011161123A2 (fr) | 2010-06-21 | 2011-12-29 | Krka, Tovarna Zdravil, D.D., Novo Mesto | Comprimé pharmaceutique multicouche comprenant du telmisartan et un diurétique |
EP2952196A4 (fr) * | 2013-01-31 | 2016-08-03 | Sawai Seiyaku Kk | Comprimé multicouche contenant du telmisartan et de l'hydrochlorothiazide |
US10111858B2 (en) | 2013-07-23 | 2018-10-30 | Daiichi Sankyo Company, Limited | Pharmaceutical for prophylaxis or treatment of hypertension |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106562973A (zh) * | 2016-11-06 | 2017-04-19 | 成都先先先生物科技有限公司 | 一种抗高血压药物复方制剂 |
CN107501192A (zh) * | 2017-08-15 | 2017-12-22 | 中国科学院上海药物研究所 | 替米沙坦与氢***的共晶 |
CN108653227A (zh) * | 2018-08-09 | 2018-10-16 | 湖北舒邦药业有限公司 | 一种替米沙坦氢***片及其制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994005264A1 (fr) * | 1992-09-01 | 1994-03-17 | Boehringer Mannheim Gmbh | Comprime oblong secable |
WO2003059327A1 (fr) * | 2002-01-16 | 2003-07-24 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Comprime pharmaceutique bicouche comprenant du telmisartane et un diuretique et preparation dudit comprime |
-
2005
- 2005-12-09 JP JP2007545905A patent/JP2008524136A/ja active Pending
- 2005-12-09 EP EP05814002A patent/EP1827424A1/fr not_active Withdrawn
- 2005-12-09 BR BRPI0519656-6A patent/BRPI0519656A2/pt not_active Application Discontinuation
- 2005-12-09 WO PCT/EP2005/013224 patent/WO2006063737A1/fr active Application Filing
- 2005-12-09 EA EA200701159A patent/EA200701159A1/ru unknown
- 2005-12-09 CN CNA2005800434334A patent/CN101080225A/zh active Pending
- 2005-12-09 CA CA002589493A patent/CA2589493A1/fr not_active Abandoned
- 2005-12-09 KR KR1020077016354A patent/KR20070097511A/ko not_active Application Discontinuation
- 2005-12-09 AU AU2005315855A patent/AU2005315855A1/en not_active Abandoned
- 2005-12-15 PE PE2005001465A patent/PE20060768A1/es not_active Application Discontinuation
- 2005-12-16 AR ARP050105303A patent/AR052052A1/es unknown
- 2005-12-16 TW TW094144909A patent/TW200637546A/zh unknown
- 2005-12-20 UY UY29274A patent/UY29274A1/es not_active Application Discontinuation
-
2007
- 2007-05-04 NO NO20072325A patent/NO20072325L/no not_active Application Discontinuation
- 2007-06-14 IL IL183944A patent/IL183944A0/en unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994005264A1 (fr) * | 1992-09-01 | 1994-03-17 | Boehringer Mannheim Gmbh | Comprime oblong secable |
WO2003059327A1 (fr) * | 2002-01-16 | 2003-07-24 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Comprime pharmaceutique bicouche comprenant du telmisartane et un diuretique et preparation dudit comprime |
Non-Patent Citations (6)
Title |
---|
ANONYMOUS: "Micardis HCT (telmisartan and hydrochlorothiazide) Tablets, 40mg/12.5 mg 80 mg/12.5 mg and 80 mg/25 mg", BOEHRINGER INGELHEIM, 19 April 2004 (2004-04-19), XP002365096, Retrieved from the Internet <URL:http://www.fda.gov/medwatch/SAFETY/2004/apr_PI/MicardisHCT_PI.pdf> [retrieved on 20060130] * |
FREYTAG FRANK ET AL: "Long-term exposure to telmisartan as monotherapy or combination therapy: Efficacy and safety", BLOOD PRESSURE, vol. 11, no. 3, 2002, pages 173 - 181, XP009060475, ISSN: 0803-7051 * |
NEUTEL JOEL M ET AL: "Long-term efficacy and tolerability of telmisartan as monotherapy and in combination with other antihypertensive medications.", BLOOD PRESSURE. 2002, vol. 11, no. 5, 2002, pages 302 - 309, XP009060476, ISSN: 0803-7051 * |
RAM C VENTIKA S: "Antihypertensive efficacy of angiotensin receptor blockers in combination with hydrochlorothiazide: a review of the factorial-design studies.", JOURNAL OF CLINICAL HYPERTENSION (GREENWICH, CONN.) OCT 2004, vol. 6, no. 10, October 2004 (2004-10-01), pages 569 - 577, XP009060495, ISSN: 1524-6175 * |
WHITE W ET AL: "Telmisartan plus hydrochlorothiazide (80/25 mg) has a greater antihypertensive effect than valsartan plus hydrochlorothiazide (160/25 mg) in patients with stage 1 and 2 hypertension", AMERICAN JOURNAL OF HYPERTENSION, ELSEVIER, vol. 18, no. 5, May 2005 (2005-05-01), pages A97, XP004895902, ISSN: 0895-7061 * |
WHITE WILLIAM B ET AL: "Effects of the angiotensin II receptor blockers telmisartan versus valsartan on the circadian variation of blood pressure Impact on the early morning period", AMERICAN JOURNAL OF HYPERTENSION, vol. 17, no. 4, April 2004 (2004-04-01), pages 347 - 353, XP002365097, ISSN: 0895-7061 * |
Cited By (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7867991B2 (en) | 2002-08-10 | 2011-01-11 | Bethesda Pharmaceuticals, Inc. | Compositions comprising novel PPAR ligands and anti-hyperlipemic agents |
US7812046B2 (en) | 2002-08-10 | 2010-10-12 | Bethesda Pharmaceuticals, Inc. | PPAR ligands that do not cause fluid retention, edema or congestive heart failure |
WO2007060170A3 (fr) * | 2005-11-24 | 2007-09-13 | Boehringer Ingelheim Int | Comprimé bicouche comprenant du telmisartan et un diurétique |
WO2007060170A2 (fr) * | 2005-11-24 | 2007-05-31 | Boehringer Ingelheim International Gmbh | Comprimé bicouche comprenant du telmisartan et un diurétique |
US8637078B2 (en) | 2005-11-24 | 2014-01-28 | Boehringer Ingelheim International Gmbh | Bilayer tablet comprising telmisartan and diuretic |
US20100143465A1 (en) * | 2007-03-14 | 2010-06-10 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition |
JP2010530844A (ja) * | 2007-03-14 | 2010-09-16 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 医薬組成物 |
EP2180882B2 (fr) † | 2007-10-19 | 2017-06-28 | Otsuka Pharmaceutical Co., Ltd. | Préparation pharmaceutique à matrice solide |
US9289389B2 (en) | 2007-10-19 | 2016-03-22 | Otsuka Pharmaceutical Co., Ltd. | Method for producing matrix-type pharmaceutical solid preparation |
US9072670B2 (en) * | 2007-10-19 | 2015-07-07 | Otsuka Pharmaceutical Co., Ltd. | Matrix-type pharmaceutical solid preparation |
US20100233265A1 (en) * | 2007-10-19 | 2010-09-16 | Kai Suzuki | Matrix-type pharmaceutical solid preparation |
US20150150806A1 (en) * | 2007-10-19 | 2015-06-04 | Otsuka Pharmaceutical Co., Ltd. | Method for producing matrix-type pharmaceutical solid preparation |
EP2203158A2 (fr) | 2007-10-30 | 2010-07-07 | Dr. Reddy's Laboratories, Ltd. | Formulations pharmaceutiques comprenant du telmisartan et de l'hydrochlorotiazide |
EP2252273A1 (fr) | 2008-03-19 | 2010-11-24 | Ratiopharm GmbH | Composition pharmaceutique solide incluant un antagoniste non peptidique du récepteur de l angiotensine ii et un diurétique |
EP2252273B1 (fr) * | 2008-03-19 | 2016-12-28 | ratiopharm GmbH | Composition pharmaceutique solide incluant un antagoniste non peptidique du récepteur de l'angiotensine ii et un diurétique |
WO2010013835A3 (fr) * | 2008-07-31 | 2010-06-10 | Takeda Pharmaceutical Company Limited | Composition pharmaceutique solide |
US9169238B2 (en) | 2008-07-31 | 2015-10-27 | Takeda Pharmaceutical Company Limited | Solid pharmaceutical composition |
WO2010013835A2 (fr) * | 2008-07-31 | 2010-02-04 | Takeda Pharmaceutical Company Limited | Composition pharmaceutique solide |
WO2010063995A3 (fr) * | 2008-12-04 | 2010-11-25 | Arrow International Limited | Telmisartan en formulations diurétiques |
WO2010063995A2 (fr) * | 2008-12-04 | 2010-06-10 | Arrow International Limited | Telmisartan en formulations diurétiques |
WO2010146187A2 (fr) | 2009-06-19 | 2010-12-23 | Krka, Tovarna Zdravil, D.D., Novo Mesto | Procédé pour la préparation de telmisartan |
WO2011002423A3 (fr) * | 2009-07-02 | 2011-03-03 | Mahmut Bilgic | Composition pharmaceutique augmentant la solubilité |
WO2011002425A3 (fr) * | 2009-07-02 | 2011-03-03 | Bilgig Mahmut | Composition pharmaceutique présentant une solubilité et une stabilité accrues |
WO2011025467A1 (fr) | 2009-08-24 | 2011-03-03 | Bilgic Mahmut | Formes posologiques solides comprenant du telmisartan |
WO2011161123A2 (fr) | 2010-06-21 | 2011-12-29 | Krka, Tovarna Zdravil, D.D., Novo Mesto | Comprimé pharmaceutique multicouche comprenant du telmisartan et un diurétique |
EP2952196A4 (fr) * | 2013-01-31 | 2016-08-03 | Sawai Seiyaku Kk | Comprimé multicouche contenant du telmisartan et de l'hydrochlorothiazide |
US10111858B2 (en) | 2013-07-23 | 2018-10-30 | Daiichi Sankyo Company, Limited | Pharmaceutical for prophylaxis or treatment of hypertension |
Also Published As
Publication number | Publication date |
---|---|
PE20060768A1 (es) | 2006-09-29 |
IL183944A0 (en) | 2007-10-31 |
EP1827424A1 (fr) | 2007-09-05 |
CN101080225A (zh) | 2007-11-28 |
TW200637546A (en) | 2006-11-01 |
BRPI0519656A2 (pt) | 2009-03-03 |
AU2005315855A1 (en) | 2006-06-22 |
CA2589493A1 (fr) | 2006-06-22 |
EA200701159A1 (ru) | 2007-12-28 |
AR052052A1 (es) | 2007-02-28 |
KR20070097511A (ko) | 2007-10-04 |
NO20072325L (no) | 2007-07-06 |
JP2008524136A (ja) | 2008-07-10 |
UY29274A1 (es) | 2006-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1827424A1 (fr) | Therapie combinatoire impliquant le telmisartan et l'hydrochlorothiazide | |
US20060159747A1 (en) | Telmisartan and hydrochlorothiazide combination therapy | |
AU2008203182B2 (en) | Bilayer pharmaceutical tablet comprising telmisartan and a diuretic and preparation thereof | |
AU2005300787B2 (en) | Bilayer tablet comprising telmisartan and amlodipine | |
US20050186274A1 (en) | Multilayer tablet | |
US20060078615A1 (en) | Bilayer tablet of telmisartan and simvastatin | |
US20130143937A1 (en) | Chlorthalidone combinations | |
EP2252273B1 (fr) | Composition pharmaceutique solide incluant un antagoniste non peptidique du récepteur de l'angiotensine ii et un diurétique | |
EP1959934A2 (fr) | Comprime bicouche comprenant du telmisartan et un diuretique | |
CA2801020A1 (fr) | Preparation pharmaceutique stable contenant du telmisartan et de l'hydrochlorothiazide | |
MX2007007046A (en) | Combination therapy comprising telmisartan and hydrochlorothiazide | |
WO2008134047A1 (fr) | Procédés de traitement de l'hypertension | |
WO2010063995A2 (fr) | Telmisartan en formulations diurétiques |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KN KP KR KZ LC LK LR LS LT LU LV LY MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2005814002 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2589493 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 07059215 Country of ref document: CO |
|
WWE | Wipo information: entry into national phase |
Ref document number: MX/a/2007/007046 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007545905 Country of ref document: JP Ref document number: 183944 Country of ref document: IL Ref document number: 4579/DELNP/2007 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12007501250 Country of ref document: PH |
|
WWE | Wipo information: entry into national phase |
Ref document number: 200580043433.4 Country of ref document: CN |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005315855 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 556271 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1200701418 Country of ref document: VN Ref document number: 1020077016354 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 200701159 Country of ref document: EA |
|
ENP | Entry into the national phase |
Ref document number: 2005315855 Country of ref document: AU Date of ref document: 20051209 Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 2005315855 Country of ref document: AU |
|
WWP | Wipo information: published in national office |
Ref document number: 2005814002 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 183944 Country of ref document: IL |
|
ENP | Entry into the national phase |
Ref document number: PI0519656 Country of ref document: BR |